BPO bioprospect limited

Baillieu Holst have just put out a BUY recommendation on BPO...

  1. 11 Posts.
    Baillieu Holst have just put out a BUY recommendation on BPO with a price target of $0.009.

    It is actually a pretty good report and very exciting if they can pull off what the company is suggesting they can. It is prfect timing with everyone targeting personal devices for different forms of health analysis and analtics.

    A pretty good punt at the current price of $0.003
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.